News
India's pharma and healthcare sector saw 57 deals worth $1.30 billion in the quarter ending June. This reflects a drop ...
The D-Street experts also suggests buying One97 Communications at a target range of Rs 1,000-Rs 1,025 with a stoploss of Rs ...
Torrent Pharma shares, currently at Rs 3,404.90, have broken out from a falling trendline, signaling a potential bullish ...
IST, the barometer index, the S&P BSE Sensex advanced 301.97 points or 0.37% to 82,556.01. The Nifty 50 index added 100.45 points or 0.40% to 25,184.35.
The central government has regulated prices for 71 essential medicines. This includes drugs for breast cancer, allergies, and ...
Ahmedabad: Torrent Pharma has appointed Manish Kainth as its Chief Human Resources Officer (CHRO).In a LinkedIn post, Kainth ...
The transaction marks a significant step in Torrent’s ambition to create a future-ready, diversified healthcare platform.
AstraZeneca spinout Dizal Pharmaceuticals won an FDA accelerated approval for sunvozertinib for previously treated EGFR ex 20 ...
Torrent Pharmaceuticals is set to acquire an additional 2.41% stake in J.B. Chemicals & Pharmaceuticals from a group of ...
The acquisition involves Torrent Pharma buying a 46.39 per cent stake from global investment firm KKR and an additional 2.8 per cent from JBCP employees, both at INR 1,600 per share ...
Torrent Pharmaceutical Ltd. will buy J. B. Chemicals and Pharmaceuticals Ltd. (JB Pharma) from private equity firm KKR & Co.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results